Frederik Persson
@frederikpersson
Diabetes complications research.
ID: 192005419
17-09-2010 23:01:24
1,1K Tweet
570 Takipçi
429 Takip Edilen
Patients with type 1 diabetes and albuminuria have a reduced brain glycolytic capability that is correlated with brain atrophy pubmed.ncbi.nlm.nih.gov/37869511/ Steno Diabetes Center Copenhagen Jens Christian Laursen
Lets test finerenone for CKD in type 1 diabetes!: see design of a randomised phase III registration trial investigating finerenone in The FINE-ONE trial - Diabetes Research and Clinical Practice diabetesresearchclinicalpractice.com/article/S0168-… Steno Diabetes Center Copenhagen
Aldosterone Synthase Inhibition in CKD ! see results Friday 11.15 at #Kidneywk late breaking trials and design paper out now karger.com/ajn/article/do… Steno Diabetes Center Copenhagen Katherine Tuttle
So aldosterone synthase inhibition reduces uacr in CKD up to 37 % with similar benefit in people randomized to sglt2i or placebo #kidneywk Steno Diabetes Center Copenhagen Katherine Tuttle
If you are interested in being an Editor-in-Chief here is your opportunity!! National Kidney Foundation is looking for an outstanding EIC for Kidney Medicine. Please apply by Dec 15.
4/5 voksne med diabetes har oplevet stigma. Det er til skade for helbredet ❌ På Verdens diabetesdag har Steno-centrene over hele landet skrevet under på ’Løftet’ imod stigma og diskrimination af personer med diabetes enddiabetesstigma.org/danish-dansk/ #EndDiabetesStigma #dkpol #diabetes
According to a nationwide study, many #T1D adults report high #diabetesdistress. With clinical factors linked to distress, follow-up strategies should prioritize identifying and reducing distress. ADA Professional Publications Read Here➡️doi.org/10.2337/dc23-1…
Impressive study with PET/CT investigating increased sub-clinical coronary artery pathology in type 2 diabetes with albuminuria by Ida KB Rasmussen diabetesjournals.org/diabetes/artic… Steno Diabetes Center Copenhagen
Steno skal være et forsknings- og udviklingshospital til gavn for hele sundhedsvæsenet, fortæller direktør Magnus T Jensen i interview med Dagens Medicin. #dkpol #sundpol Læs artiklen her👇 dagensmedicin.dk/steno-direktoe…
Aldosterone synthase inhibition reduces UACR 35-40% with or without empagliflozin in CKD, without unexpected safety signals. Demonstrating benefit of combination treatment in CKD Katherine Tuttle Steno Diabetes Center Copenhagen Hiddo Heerspink The Lancet sciencedirect.com/science/articl…
Look at this CKD progression paper led by Reimar Thomsen with Anne Høy Seemann Vestergaard and others. Based on nationwide data. Risk factor analysis for a rapid progression of chronic kidney disease academic.oup.com/ndt/article/do… Peter Rossing Steno Diabetes Center Copenhagen Brendon Neuen
Did you know? There is an Association of carpal tunnel syndrome with incident diabetes Work from Jeppe Ravn Jacobsen in a #cardiometabolic collaboration with Steno Diabetes Center Copenhagen Peter Rossing Emil Fosbøl and others …ubs.pericles-prod.literatumonline.com/doi/10.1111/do…
Read a review on combination therapies for kidney disease in people with diabetes doi.org/10.1038/s41581… Steno Diabetes Center Copenhagen Peter Rossing Petter Bjornstad, M.D. Katherine Tuttle Sylvia Rosas,MD,MSCE and many others
New Review! Combination therapy for kidney disease in people with diabetes by D. van Raalte, Petter Bjornstad, M.D., D. Cherney, I. de Boer, P. Fioretto, D. Gordin, Frederik Persson, Sylvia Rosas,MD,MSCE, Peter Rossing, J. Schaub, Katherine Tuttle, Sushrut Waikar & H. Heerspink go.nature.com/4aB7lh8
Great first day of the Europe Diabetic Study Group EDNSG annual meeting at Steno Ruth Østerby prize to Karin Jandeleith Dahm⭐️ And great presentations on all aspects of diabetic kidney disease Steno Diabetes Center Copenhagen Frederik Persson #EDNSG2024
#EDNSG2024 starting day 2 at Steno Diabetes Center Copenhagen with lecture by prof Christian Delles from Glasgow on aldosterone in CKD and heart disease
Wonderful to be part of the great team presenting FLOW semaglutide in T2D with CKD #ERA2024 today with benefit on major kidney and CV outcomes including all cause mortality 👍 Steno Diabetes Center Copenhagen
